Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 51 - 90 av 90 resultater
Tid
Selskap
Tittel
Sektor
Kategori
18 Jul 2022
17:45 CEST
THERANEXUS
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ DE THERANEXUS CONCLU AVEC LA SOCIÉTÉ PORTZAMPARC
20103010 Biotechnology
Legal
12 Jul 2022
18:00 CEST
THERANEXUS
Theranexus publishes its cash position as of 30 june 2022
20103010 Biotechnology
Legal
12 Jul 2022
18:00 CEST
THERANEXUS
Theranexus publie sa position de trésorerie au 30 juin 2022
20103010 Biotechnology
Legal
09 Jun 2022
18:00 CEST
THERANEXUS
THERANEXUS PARTICIPERA À PLUSIEURS CONGRÈS SCIENTIFIQUES ET CONVENTIONS D'AFFAIRES DE RÉFÉRENCE
20103010 Biotechnology
Legal
09 Jun 2022
18:00 CEST
THERANEXUS
THERANEXUS PARTICIPATES IN SEVERAL LEADING SCIENTIFIC CONFERENCES AND BUSINESS CONVENTIONS
20103010 Biotechnology
Legal
07 Jun 2022
18:00 CEST
THERANEXUS
ASSEMBLÉE GÉNÉRALE DU 22 JUIN 2022 : MISE À DISPOSITION DES DOCUMENTS PRÉPARATOIRES
20103010 Biotechnology
General meeting / Board Meeting, Meetings / events
25 May 2022
18:00 CEST
THERANEXUS
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
Change in Capital
29 Apr 2022
18:25 CEST
THERANEXUS
Mise à disposition du document d'enregistrement universel 2021
20103010 Biotechnology
Legal
25 Apr 2022
09:20 CEST
THERANEXUS
Theranexus publishes its 2021 full-year results And announces a shift of its strategic focus to rare neurological diseases
20103010 Biotechnology
Sales, Income, Commercial results
25 Apr 2022
09:15 CEST
THERANEXUS
Theranexus publie ses résultats annuels 2021 Et annonce son évolution stratégique vers les maladies neurologiques rares
20103010 Biotechnology
Sales, Income, Commercial results
25 Apr 2022
07:00 CEST
THERANEXUS
Theranexus publishes its 2021 full-year results And announces a shift of its strategic focus to rare neurological diseases
20103010 Biotechnology
Sales, Income, Commercial results
25 Apr 2022
07:00 CEST
THERANEXUS
Theranexus publie ses résultats annuels 2021 et annonce son évolution stratégique vers les maladies neurologiques rares
20103010 Biotechnology
Sales, Income, Commercial results
06 Apr 2022
18:00 CEST
THERANEXUS
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
Change in Capital
23 Mar 2022
18:00 CET
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
28 Feb 2022
07:30 CET
THERANEXUS
THERANEXUS UNVEILS ITS SCIENTIFIC ADVANCES ON THE OCCASION OF WORLD RARE DISEASE DAY 2022
20103010 Biotechnology
Legal
28 Feb 2022
07:30 CET
THERANEXUS
À L'OCCASION DE LA JOURNÉE MONDIALE DES MALADIES RARES 2022, THERANEXUS DÉVOILE SES AVANCÉES SCIENTIFIQUES
20103010 Biotechnology
Legal
10 Feb 2022
18:40 CET
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
03 Feb 2022
18:00 CET
THERANEXUS
THERANEXUS ET LA FONDATION BBDF INITIENT LE RECRUTEMENT POUR L'ÉTUDE DE PHASE I/II DANS LA MALADIE DE BATTEN
20103010 Biotechnology
Legal
03 Feb 2022
18:00 CET
THERANEXUS
THERANEXUS AND BBDF START RECRUITMENT FOR PHASE I/II TRIAL IN BATTEN DISEASE PATIENTS
20103010 Biotechnology
Legal
13 Jan 2022
18:00 CET
THERANEXUS
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2021 - MISE EN PLACE D'UNE NOUVELLE LIGNE DE FINANCEMENT EN FONDS PROPRE
20103010 Biotechnology
Legal
13 Jan 2022
18:00 CET
THERANEXUS
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2021 - IMPLEMENTATION OF A NEW EQUITY LINE
20103010 Biotechnology
Legal
06 Jan 2022
18:00 CET
THERANEXUS
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 2ND SEMESTRE 2021
20103010 Biotechnology
Legal
04 Jan 2022
18:00 CET
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
20 Dec 2021
18:00 CET
THERANEXUS
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2022
20103010 Biotechnology
Legal
20 Dec 2021
18:00 CET
THERANEXUS
THERANEXUS PUBLIE SON AGENDA FINANCIER 2022
20103010 Biotechnology
Legal
13 Dec 2021
18:00 CET
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
15 Nov 2021
18:00 CET
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
19 Oct 2021
18:00 CEST
THERANEXUS
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 SEPTEMBER 2021 AND PRESENTS ITS PROGRESS REPORT
20103010 Biotechnology
Legal
19 Oct 2021
18:00 CEST
THERANEXUS
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 SEPTEMBRE 2021 ET FAIT LE POINT SUR SES AVANCÉES
20103010 Biotechnology
Legal
01 Oct 2021
18:00 CEST
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
30 Sep 2021
18:00 CEST
THERANEXUS
THERANEXUS ANNOUNCES ITS FIRST HALF 2021 RESULTS
20103010 Biotechnology
Sales, Income, Commercial results
30 Sep 2021
18:00 CEST
THERANEXUS
RAPPORT SEMESTRIEL 2021
20103010 Biotechnology
Legal
30 Sep 2021
18:00 CEST
THERANEXUS
THERANEXUS ANNONCE SES RÉSULTATS DU PREMIER SEMESTRE 2021
20103010 Biotechnology
Sales, Income, Commercial results
21 Sep 2021
18:00 CEST
THERANEXUS
Publication mensuelle du nombre d'actions composant le capital et du nombre total de droits de vote
20103010 Biotechnology
Change in Capital
09 Sep 2021
18:00 CEST
THERANEXUS
THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION (BBDF) WIN US INVESTIGATIONAL NEW DRUG (IND) APPROVAL TO START CLINICAL DEVELOPMENT OF BBDF 101
20103010 Biotechnology
Legal
09 Sep 2021
18:00 CEST
THERANEXUS
THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE (BBDF) OBTIENNENT LE STATUT D'INVESTIGATIONAL NEW DRUG (IND) AUX ÉTATS-UNIS POUR DÉMARRER LE DÉVELOPPEMENT CLINIQUE DE BBDF 101
20103010 Biotechnology
Legal
03 Aug 2021
18:00 CEST
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
28 Jul 2021
18:00 CEST
THERANEXUS
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL
20103010 Biotechnology
Change in Capital
08 Jul 2021
18:00 CEST
THERANEXUS
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 JUIN 2021 ET FAIT UN POINT SUR L'AVANCEMENT DE SES PRINCIPAUX PROGRAMMES
20103010 Biotechnology
Other subject
08 Jul 2021
18:00 CEST
THERANEXUS
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2021 AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS MAIN PROGRAMS
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
1
2
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva